Who owns Milestone Pharmaceuticals Inc., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
Pavaki Capital Management LLC: 7.3% · 9,067,848 shares — Pavaki Capital Partners, LP: 7.3% · 9,067,848 shares — Ashok Rambhai Patel: 7.3% · 9,067,848 shares
RTW Investments, LP: 9.9% · 12,356,953 shares — Roderick Wong: 9.9% · 12,356,953 shares
5 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of Milestone Pharmaceuticals Inc..
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Milestone Pharmaceuticals Inc. they hold. Together these 104 managers report 45.57% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| Pavaki Capital Management LLC | $12.2M | 9,067,848 | 4.24% | 7.28% | June 30, 2026 |
| RTW INVESTMENTS, LP | $10.5M | 7,833,336 | 0.09% | 6.29% | June 30, 2026 |
102 more institutional holders behind a free account
See every manager reporting Milestone Pharmaceuticals Inc., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 5 funds hold 1.32% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| Simplify Propel Opportunities ETF | $1.79M | 2.58% | 1.21% | March 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | $127K | 0.00% | 0.06% | February 28, 2026 |
3 more funds behind a free account
See every fund holding Milestone Pharmaceuticals Inc. and what share of its net assets the position represents.
Sign up freeLoading...
